Adipo Therapeutics

Adipo Therapeutic is a biotechnology company that is developing a novel asset for the treatment of obesity by increasing energy expenditure via mitochondria biogenesis and activation in white adipose tissue (fat browning).

Based based in United States, Adipo Therapeutics works in food & beverage.

Profile

Adipo Therapeutics is a biotechnology company developing innovative treatments for obesity and metabolic diseases by increasing energy expenditure through mitochondrial biogenesis and activation in white adipose tissue. The company’s novel approach utilizes Notch-inhibiting nanoparticles to induce the conversion of energy-storing white fat into metabolically active brown fat, promoting weight loss without the need for calorie restriction. This strategy addresses limitations of traditional weight loss methods that often reduce resting metabolic rate. Preclinical and ex-vivo human tissue studies have demonstrated promising outcomes, including weight reduction and improved blood glucose and lipid regulation. By pioneering fat browning technology, Adipo Therapeutics contributes to advancing metabolic disease treatment and offers a potential new paradigm in obesity management.

As a business in food & beverage, Adipo Therapeutics is listed here with the public details available about it.

Its base of operations is United States.

Directory data places it at the Plug and Play accelerated startup stage.

Website: adipotherapeutics.com